|
Rheumatoid Arthritis
Citations 221-230 of 841 total displayed.
|
Past content
(since Feb 2000):
|
- CLINICAL
Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register
- J. A. Karlsson, L. E. Kristensen, M. C. Kapetanovic, A. Gülfe, T. Saxne, and P. Geborek
Rheumatology 2008; 47: 507-513.
[Abstract]
[Full Text]
- CLINICAL
Disease Activity Score 28-ESR bears a similar relationship to treatment decisions across different rheumatologists, but misclassification is too frequent to replace physician judgement
- W. J. Taylor, A. A. Harrison, J. Highton, P. Chapman, L. Stamp, J. Dockerty, F. McQueen, P. B. B. Jones, D. Ching, D. Porter, C. Rajapakse, S. R. Rudge, G. Taylor, S. Kumar, T. Macedo, and M. Sew Hoy
Rheumatology 2008; 47: 514-518.
[Abstract]
[Full Text]
- CLINICAL
Low disease activity state with corticosteroid may not represent ‘true’ low disease activity state in patients with rheumatoid arthritis
- N. Iikuni, E. Inoue, E. Tanaka, M. Hara, T. Tomatsu, N. Kamatani, and H. Yamanaka
Rheumatology 2008; 47: 519-521.
[Abstract]
[Full Text]
- CLINICAL
Cost–effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate
- M. Vera-Llonch, E. Massarotti, F. Wolfe, N. Shadick, R. Westhovens, O. Sofrygin, R. Maclean, Y. Yuan, and G. Oster
Rheumatology 2008; 47: 535-541.
[Abstract]
[Full Text]
- LETTERS TO THE EDITOR
Shared familial risk factors between cancer and RA patients
- K. Hemminki, X. Li, K. Sundquist, and J. Sundquist
Rheumatology 2008; 47: 549-551.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: The pharmacogenetics of methotrexate: reply
- S. Hider, I. Bruce, and W. Thomson
Rheumatology 2008; 47: 557-a--a558.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: The pharmacogenetics of methotrexate
- S. M. van der Kooij, J. A. M. Wessels, T. W. J. Huizinga, and H.-J. Guchelaar
Rheumatology 2008; 47: 557.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists
- R. S. Sandhu, G. J. Treharne, E. A. Justice, A. C. Jordan, S. Saravana, K. Obrenovic, N. Erb, G. D. Kitas, and I. F. Rowe on behalf of the West Midlands Rheumatology Services and Training Committee
Rheumatology 2008; 47: 559-560.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists: reply
- K. Kumar and K. Raza
Rheumatology 2008; 47: 560.
[Extract]
[Full Text]
- EDITORIALS
The role of specialists in managing established rheumatoid arthritis
- D. L. Scott and D. P. M. Symmons
Rheumatology 2008; 47: 237-238.
[Extract]
[Full Text]
|
|
